Authors:
L Deng, L Shang, S Bai, J Chen, X He, R Martin-Trevino, S Chen, X-Y Li, X Meng, B Yu, X Wang, Y Liu, SP McDermott, AE Ariazi, C Ginestier, I Ibarra, J Ke, T Luther, SG Clouthier, L Xu, G Shan, E Song, H Yao, GJ Hannon, SJ Weiss, MS Wicha, S Liu
Journal name: 
Cancer Res
Citation info: 
74(22):6648-6660
Abstract: 
miRNAs are essential for self-renewal and differentiation of normal and malignant stem cells by regulating the expression of key stem cell regulatory genes. Here, we report evidence implicating the miR100 in self-renewal of cancer stem-like cells (CSC). We found that miR100 expression levels relate to the cellular differentiation state, with lowest expression in cells displaying stem cell markers. Utilizing a tetracycline-inducible lentivirus to elevate expression of miR100 in human cells, we found that increasing miR100 levels decreased the production of breast CSCs. This effect was correlated with an inhibition of cancer cell proliferation in vitro and in mouse tumor xenografts due to attenuated expression of the CSC regulatory genes SMARCA5, SMARCD1, and BMPR2. Furthermore, miR100 induction in breast CSCs immediately upon their orthotopic implantation or intracardiac injection completely blocked tumor growth and metastasis formation. Clinically, we observed a significant association between miR100 expression in breast cancer specimens and patient survival. Our results suggest that miR100 is required to direct CSC self-renewal and differentiation.
DOI: 
http://doi.org/10.1158/0008-5472.CAN-13-3710
Research group: 
Hannon Group
E-pub date: 
15 Nov 2014